The SeaStar Medical Holding Corporation (ICU) share price is expected to increase by 267.35% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered ICU. Price targets range from $18 at the low end to $18 at the high end. The current analyst consensus for ICU is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedICU 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect SeaStar Medical Holding Corporation to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ICU. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ICU.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Anthony Vendetti Maxim Group | Buy | $5 | Initiates | Apr 20, 2023 |
When did it IPO
2021
Staff Count
12
Country
United States
Sector/Industry
Healthcare/Biotechnology
CEO
Mr. Eric Schlorff
Market Cap
$23.1M
In 2023, ICU generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ICU's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.